Glucose-6-phosphate dehydrogenase, the rate-limiting enzyme in the pentose phosphate pathway, is highly active in the brain and its dysregulation has been implicated in neurodegenerative diseases (63, 64). This evidence concerns the gene G6PD and neurodegenerative disease.